Ignite Creation Date:
2025-12-24 @ 4:56 PM
Ignite Modification Date:
2025-12-27 @ 9:46 PM
Study NCT ID:
NCT04991350
Status:
TERMINATED
Last Update Posted:
2023-02-16
First Post:
2021-07-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema
Sponsor:
Cairo University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-26
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-01
Completion Date Type:
ACTUAL
First Submit Date:
2021-07-24
First Submit QC Date:
None
Study First Post Date:
2021-08-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-15
Last Update Post Date:
2023-02-16
Last Update Post Date Type:
ACTUAL